Bibliotecas PUC-SP - Busca Integrada

Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure

Por Thomas Prébet, Sylvain Thepot, Steven D. Gore, François Dreyfus, Pierre Fenaux, Norbert Vey
Publicado no Haematologica (2013-02-01)

Epigenetics in Cancer: A Hematological Perspective.

Por Maximilian Stahl, Nathan Kohrman, Steven D Gore, Tae Kon Kim, Amer M Zeidan, Thomas Prebet
Publicado no PLoS Genetics (2016-10-01)

Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes

Por Sheila Weiss Smith, Masayo Sato, Steven D. Gore, Maria R. Baer, Xuehua Ke, Diane McNally, Amy Davidoff
Publicado no Haematologica (2012-01-01)

Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

Por Dan P. Zandberg, Ting-Ying Huang, Xuehua Ke, Maria R. Baer, Steven D. Gore, Sheila Weiss Smith, Amy J. Davidoff
Publicado no Haematologica (2013-04-01)

Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies.

Por Eric Laille, Tao Shi, Guillermo Garcia-Manero, Christopher R Cogle, Steven D Gore, Joel Hetzer, Keshava Kumar, Barry Skikne, Kyle J MacBeth
Publicado no PLoS ONE (2015-01-01)

Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes

Por Amy J. Davidoff, Sheila Weiss Smith, Maria R. Baer, Xuehua Ke, Jason M. Bierenbaum, Franklin Hendrick, Diane L. McNally, Steven D. Gore
Publicado no Haematologica (2012-01-01)

High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids

Por Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, Poorva Juneja, Eric Jones, Steven D. Gore, Mark W. Kunkel, James H. Doroshow, Beverly A. Teicher
Publicado no SLAS Discovery (2025-12-01)

A phase 2 study of vorinostat in acute myeloid leukemia

Por Eric W. Schaefer, Arturo Loaiza-Bonilla, Mark Juckett, John F. DiPersio, Vivek Roy, James Slack, Wenting Wu, Kristina Laumann, Igor Espinoza-Delgado, Steven D. Gore
Publicado no Haematologica (2009-10-01)

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care...

Por Steven D. Gore, Pierre Fenaux, Valeria Santini, John M. Bennett, Lewis R. Silverman, John F. Seymour, Eva Hellström-Lindberg, Arlene S. Swern, Charles. L. Beach, Alan. F. List
Publicado no Haematologica (2013-07-01)

Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia

Por Nikolai A. Podoltsev, Rong Wang, Rory M. Shallis, Jessica M. Stempel, Mengyang Di, Natalia Neparidze, Amer M. Zeidan, Scott F. Huntington, Smith Giri, Sarah C. Hull, Steven D. Gore, Xiaomei Ma
Publicado no Cancer Medicine (2023-09-01)

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia

Por Brian Ball, Rami S. Komrokji, Lionel Adès, Mikkael A. Sekeres, Amy E. DeZern, Lisa Pleyer, Norbert Vey, Antonio Almeida, Ulrich Germing, Thomas Cluzeau, Uwe Platzbecker, Steven D. Gore, Pierre Fenaux, Thomas Prebet
Publicado no Blood Advances (2018-08-01)

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.

Por Amer M Zeidan, Jessica B Long, Rong Wang, Xin Hu, James B Yu, Scott F Huntington, Gregory A Abel, Sarah S Mougalian, Nikolai A Podoltsev, Steven D Gore, Cary P Gross, Xiaomei Ma, Amy J Davidoff
Publicado no PLoS ONE (2017-01-01)

A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms

Por Joshua F. Zeidner, Judith E. Karp, Amanda L. Blackford, B. Douglas Smith, Ivana Gojo, Steven D. Gore, Mark J. Levis, Hetty E. Carraway, Jacqueline M. Greer, S. Percy Ivy, Keith W. Pratz, Michael A. McDevitt
Publicado no Haematologica (2014-04-01)

The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia

Por John Barrett, Stephen J Forman, Jeffrey S Miller, Jill Brufsky, Jorge Cortes, Marcos de Lima, Michael M Boyiadzis, Ivan Aksentijevich, Daniel A Arber, Renier J Brentjens, Ephraim J Fuchs, Linda J Fukas, Steven D Gore, Mark R Litzow, John M Pagel, Martin S Tallman
Publicado no Journal for ImmunoTherapy of Cancer (2020-10-01)

Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk a...

Por Judith E. Karp, Elizabeth Garrett-Mayer, Elihu H. Estey, Michelle A. Rudek, B. Douglas Smith, Jacqueline M. Greer, D. Michelle Drye, Karen Mackey, Kathleen Shannon Dorcy, Steven D. Gore, Mark J. Levis, Michael A. McDevitt, Hetty E. Carraway, Keith W. Pratz, Douglas E. Gladstone, Margaret M. Showel, Megan Othus, L. Austin Doyle, John J. Wright, John M. Pagel
Publicado no Haematologica (2012-11-01)

PD-1H/VISTA mediates immune evasion in acute myeloid leukemia

Por Tae Kon Kim, Xue Han, Qianni Hu, Esten N. Vandsemb, Carly M. Fielder, Junshik Hong, Kwang Woon Kim, Emily F. Mason, R. Skipper Plowman, Jun Wang, Qi Wang, Jian-Ping Zhang, Ti Badri, Miguel F. Sanmamed, Linghua Zheng, Tianxiang Zhang, Jude Alawa, Sang Won Lee, Amer M. Zeidan, Stephanie Halene, Manoj M. Pillai, Namrata S. Chandhok, Jun Lu, Mina L. Xu, Steven D. Gore, Lieping Chen
Publicado no The Journal of Clinical Investigation (2024-02-01)

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

Por Maximilian Stahl, Michelle DeVeaux, Theo de Witte, Judith Neukirchen, Mikkael A. Sekeres, Andrew M. Brunner, Gail J. Roboz, David P. Steensma, Vijaya R. Bhatt, Uwe Platzbecker, Thomas Cluzeau, Pedro H. Prata, Raphaël Itzykson, Pierre Fenaux, Amir T. Fathi, Alexandra Smith, Ulrich Germing, Ellen K. Ritchie, Vivek Verma, Aziz Nazha, Jaroslaw P. Maciejewski, Nikolai A. Podoltsev, Thomas Prebet, Valeria Santini, Steven D. Gore, Rami S. Komrokji, Amer M. Zeidan
Publicado no Blood Advances (2018-07-01)

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Por Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, Raphael Itzykson, Ellen K. Ritchie, Mikkael A. Sekeres, John D. Barnard, Nikolai A. Podoltsev, Andrew M. Brunner, Rami S. Komrokji, Vijaya R. Bhatt, Aref Al-Kali, Thomas Cluzeau, Valeria Santini, Amir T. Fathi, Gail J. Roboz, Pierre Fenaux, Mark R. Litzow, Sarah Perreault, Tae Kon Kim, Thomas Prebet, Norbert Vey, Vivek Verma, Ulrich Germing, Juan Miguel Bergua, Josefina Serrano, Steven D. Gore, Amer M. Zeidan
Publicado no Blood Advances (2018-04-01)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia

Por Justin Kline, Ronald Levy, Joshua Brody, James N. Kochenderfer, Edmund K. Waller, Sundar Jagannath, Michael R. Bishop, David Siegel, David Avigan, Michael Boyiadzis, Jeffrey Miller, Rafat Abonour, Kenneth C. Anderson, Stephen M. Ansell, Lisa Barbarotta, Austin John Barrett, Koen Van Besien, P. Leif Bergsagel, Ivan Borrello, Jill Brufsky, Mitchell Cairo, Ajai Chari, Adam Cohen, Jorge Cortes, Stephen J. Forman, Jonathan W. Friedberg, Ephraim J. Fuchs, Steven D. Gore, Brad S. Kahl, Larry W. Kwak, Marcos de Lima, Mark R. Litzow, Anuj Mahindra, Nikhil C. Munshi, Robert Z. Orlowski, John M. Pagel, David L. Porter, Stephen J. Russell, Karl Schwartz, Margaret A. Shipp, Richard M. Stone, Martin S. Tallman, John M. Timmerman, Frits Van Rhee, Ann Welsh, Michael Werner, Peter H. Wiernik, Madhav V. Dhodapkar
Publicado no Journal for ImmunoTherapy of Cancer (2016-12-01)